[Beta blockaders--new pharmaceuticals in the treatment of migraine?].
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D008881:Migraine Disorders / Q000188:drug therapy* / Q000209:etiology; D013565:Sympatholytics / Q000627:therapeutic use*
D000317:Adrenergic alpha-Antagonists; D013565:Sympatholytics
Beta-blokade--et nytt fremskritt i migrenebehandlingen?